Homepage

CytoMed Therapeutics Limited

GDTC NASDAQ Categories PDF
Healthcare · Biotechnology · Singapore · Updated May 11, 1:51pm
$0.81
Price
$9.6M
Market Cap
43
Employees
-0.17
Beta
Chee Kong Choo
CEO
Business Description

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company's lead product candidate is CTM-N2D, which consists of expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor to improve anti-cancer cytotoxicity. It is also developing iPSC-gdNKT, which utilizes iPSC as a starting material to generate gdNKT, a synthetic hybrid of a gamma delta T cell and a NK cell; and CTM-GDT, a product candidate that consists of expanded gamma delta T cells, and exploits the multiple recognition system of gamma delta T cell to recognize and treat a range of cancers. The company was incorporated in 2018 and is headquartered in Singapore.

Business History
Price Overview
Last updated: May 11, 2026 1:51pm (just now)
$0.81
+0.03 (+4.42%)
Day Range
$0.78 – $0.86
52-Week Range
$0.68 – $3.68
50-Day MA
$1.01
200-Day MA
$1.53
Volume
11,243.00
Share Structure
Outstanding 11,832,835.00
Float 3,970,687.00
Free Float 33.6%
Moderate free float — 33.6% of shares trade freely, ~66.4% held by insiders/institutions
Reasonable but insiders still hold a significant stake. This can be positive (skin in the game) but may limit liquidity during sell-offs.
Small absolute float (4.0M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-3.13
Stock Price: $0.81
EPS (Diluted): -0.26
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
2.38
Stock Price: $0.81
Total Equity: $6.54M
Shares: 11,647,225
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
-2.12
Market Cap: $9.64M
Total Debt: $409,503
Cash: $2.10M
EBITDA: -$3.34M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$14.0M
Market Cap: $9.64M
Total Debt: $409,503
Cash: $2.10M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
-277.7%
Gross Profit: -$689,552
Revenue: $248,269
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
-1,416.0%
Operating Income: -$3.52M
Revenue: $248,269
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-1,227.1%
Net Income: -$3.05M
Revenue: $248,269
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-68.9%
Net Income: -$3.05M
Total Equity: $6.54M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-55.3%
Operating Income: -$3.52M
Tax Rate: 0.0%
Equity: $6.54M
Total Debt: $409,503
Cash: $2.10M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
5.17
Current Assets: $3.66M
Current Liabilities: $709,169
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.06
Short-Term Debt: $40,847
Long-Term Debt: $368,656
Total Debt: $409,503
Total Equity: $6.54M
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$0.02
Revenue: $248,269
Shares: 11,647,225
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$0.56
Total Equity: $6.54M
Shares: 11,647,225
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$-0.38
Operating CF: -$3.70M
CapEx: -$703,134
Shares: 11,647,225
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $0.81
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$3.05M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares GDTC against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $84,178 $0 $290,560 $52,005 $248,269
Cost of Revenue $2,590 $81,034 $2,824 $22,733 $937,821
Gross Profit $81,587 $-81,034 $381,922 $52,380 $-689,552
Operating Expenses $937,147 $1.6M $1.6M $1.9M $2.8M
Operating Income -$1.4M -$1.7M -$3.2M -$2.6M -$3.5M
Net Income -$1.5M -$2.3M -$3.1M -$1.9M -$3.0M
EBITDA -$1.0M -$1.1M -$2.9M -$1.8M -$3.3M
EPS $-0.22 $-0.30 $-0.29 $-0.16 $-0.26
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $1.9M $1.2M $6.8M $3.6M $2.1M
Total Current Assets $2.4M $1.9M $7.7M $4.4M $3.7M
Total Assets $4.5M $3.9M $9.4M $7.4M $8.0M
Current Liabilities $2.2M $3.1M $543,278 $444,180 $709,169
Long-Term Debt $399,741 $350,027 $308,997 $288,721 $368,656
Total Liabilities $2.6M $3.5M $852,276 $749,763 $1.1M
Total Equity $1.9M $438,241 $8.5M $6.6M $6.5M
Retained Earnings -$3.8M -$6.1M -$9.3M -$10.9M -$18.8M
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow -$1.3M -$1.0M -$2.7M -$2.0M -$3.7M
Capital Expenditure $-431,798 $-353,736 $-44,174 -$1.0M $-703,134
Free Cash Flow -$1.7M -$1.4M -$2.7M -$3.0M -$4.4M
Acquisitions (net) $0 $355 $0 $0 $1.2M
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks $0 $0 $0 $0 $0
Net Change in Cash $1.2M $-683,723 $3.5M -$1.3M -$2.6M
Analyst Estimates (Annual)
Metric 2023 2024 2025
Revenue $520,000
$520,000 – $520,000
 $571,000
$571,000 – $571,000
 $520,000
$520,000 – $520,000
EBITDA $-312,000
$-312,000 – $-312,000
 $-342,600
$-342,600 – $-342,600
 $-312,000
$-312,000 – $-312,000
Net Income -$3.0M
-$3.0M – -$3.0M
 -$1.7M
-$1.7M – -$1.7M
 -$2.0M
-$2.0M – -$2.0M
EPS — — —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth -100.0% — -82.1% +377.4%
Gross Profit Growth -199.3% +571.3% -86.3% -1,416.4%
Operating Income Growth -21.3% -88.5% +17.9% -33.9%
Net Income Growth -48.0% -37.9% +39.9% -61.8%
EBITDA Growth -4.5% -168.3% +39.1% -86.6%
Community AI Feedback
Sign in to Contribute
No community reviews yet for GDTC. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27